Top Big Cap Negative News Movers Premarket:  SVRA: -17% FDA Will Not Take Action on the Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) by the PDUFA Date BLTE: -17% Extension of FDA Review Timeline for Tinlarebant NDA ANT: -12% Recent IPO weakness INTU: -10% Earnings  SKM: -8.5% Weakness off ANT  BJ: -6% Earnings  ROST: -6% Earnings 20-NOV-2026 09:09 AM ET